Zachary Klaassen hosts Andrew Hahn to discuss future directions in metastatic castration-resistant prostate cancer. Dr. Hahn highlights the "golden era" for targeting cell surface proteins through ...

psa nadir 0.2, metastatic hormone sensitive prostate cancer, mHSPC treatment, PSA targets prostate cancer, PSA Thresholds in mHSPC: What VA Data Reveals About Optimal Targets with Stephen Freedland, ...

HIF-2 inhibitor kidney cancer, Casdatifan cabozantinib combination, refractory renal cell carcinoma treatment, AB-521 clinical trial, clear cell RCC therapy, Combination HIF-2α/VEGF Dual Inhibition in ...

CHAI biomarker, using AI to predict BCG vs Gem/Doce response in bladder cancer, achieving 90% success rate, insights on precision medicine, Computational Histology AI Guides Treatment Selection for ...

(UroToday.com) The 2025 AUA annual meeting featured the 4 th annual IBCG Bladder Cancer Forum evaluating common problems and controversies in bladder cancer, moderated by Dr. Neha Vapiwala with a ...

properties of Lead-212 and Actinium-225 alpha emitters for prostate cancer therapy, comparing half-lives dosing imaging capabilities and clinical trial progress with early results showing minimal ...

device using medical supplies already in operating rooms to monitor ureteral access sheath insertion force, preventing high-grade injuries, Air Force #1: Development and Initial Clinical Evaluation of ...

Bruce Gao presents an ex vivo study comparing the temperature rise of Soltive TFL, pulsed thulium:YAG, Thulio®, and MOSES holmium:YAG lasers during continuous lasering, showing that while TFL ...

In this discussion Zachary Klaassen is joined by Jay Raman and Yair Lotan to explore the latest updates in the evaluation of microhematuria. They discuss the unmet need in risk stratifying patients, ...

Focal therapy (FT) has quickly emerged over the last few decades as a prostate cancer (CaP) treatment option due to the growing research indicating more favorable side effects compared to radical ...

artificial intelligence can simplify complex radiopharmaceutical dosimetry procedures, AI-powered image enhancement, automated segmentation, registration improvement, direct dose map calculation ...

post-treatment imaging and dosimetry to personalize radiopharmaceutical therapy, SPECT imaging reveals orders-of-magnitude differences in tumor doses between patients, identifies non-responders early, ...